PD-L1 Biomarker Testing Platform Market Insights, Global Outlook and Forecast 2022-2028
PD-L1 Biomarker Testing Platform Market Insights, Global Outlook and Forecast 2022-2028
The PD L1 Biomarker Testing Platform study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
The latest research study released by Market IntelliX evaluates market size and forecasts of PD-L1 Biomarker Testing Platform in Global, including the following market information:
Global PD-L1 Biomarker Testing Platform Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PD-L1 Biomarker Testing Platform market was valued at 1513.1 million in 2021 and is projected to reach US$ 13220 million by 2028, at a CAGR of 36.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-L1(22C3) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-L1 Biomarker Testing Platform include Agilent Technologies and Roche etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the PD-L1 Biomarker Testing Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global PD-L1 Biomarker Testing Platform Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, by Type, 2021 (%)
PD-L1(22C3)
PD-L1(28-8)
PD-L1(SP142)
PD-L1(SP263)
Other
Global PD-L1 Biomarker Testing Platform Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, by Application, 2021 (%)
Hospital
Diagnostic Center
Other
Global PD-L1 Biomarker Testing Platform Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PD-L1 Biomarker Testing Platform Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD-L1 Biomarker Testing Platform revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PD-L1 Biomarker Testing Platform revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Agilent Technologies
Roche
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 PD-L1 Biomarker Testing Platform Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-L1 Biomarker Testing Platform Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PD-L1 Biomarker Testing Platform Overall Market Size
2.1 Global PD-L1 Biomarker Testing Platform Market Size: 2021 VS 2028
2.2 Global PD-L1 Biomarker Testing Platform Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PD-L1 Biomarker Testing Platform Players in Global Market
3.2 Top Global PD-L1 Biomarker Testing Platform Companies Ranked by Revenue
3.3 Global PD-L1 Biomarker Testing Platform Revenue by Companies
3.4 Top 3 and Top 5 PD-L1 Biomarker Testing Platform Companies in Global Market, by Revenue in 2021
3.5 Global Companies PD-L1 Biomarker Testing Platform Product Type
3.6 Tier 1, Tier 2 and Tier 3 PD-L1 Biomarker Testing Platform Players in Global Market
3.6.1 List of Global Tier 1 PD-L1 Biomarker Testing Platform Companies
3.6.2 List of Global Tier 2 and Tier 3 PD-L1 Biomarker Testing Platform Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global PD-L1 Biomarker Testing Platform Market Size Markets, 2021 & 2028
4.1.2 PD-L1(22C3)
4.1.3 PD-L1(28-8)
4.1.4 PD-L1(SP142)
4.1.5 PD-L1(SP263)
4.1.6 Other
4.2 By Type - Global PD-L1 Biomarker Testing Platform Revenue & Forecasts
4.2.1 By Type - Global PD-L1 Biomarker Testing Platform Revenue, 2017-2022
4.2.2 By Type - Global PD-L1 Biomarker Testing Platform Revenue, 2023-2028
4.2.3 By Type - Global PD-L1 Biomarker Testing Platform Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PD-L1 Biomarker Testing Platform Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Other
5.2 By Application - Global PD-L1 Biomarker Testing Platform Revenue & Forecasts
5.2.1 By Application - Global PD-L1 Biomarker Testing Platform Revenue, 2017-2022
5.2.2 By Application - Global PD-L1 Biomarker Testing Platform Revenue, 2023-2028
5.2.3 By Application - Global PD-L1 Biomarker Testing Platform Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global PD-L1 Biomarker Testing Platform Market Size, 2021 & 2028
6.2 By Region - Global PD-L1 Biomarker Testing Platform Revenue & Forecasts
6.2.1 By Region - Global PD-L1 Biomarker Testing Platform Revenue, 2017-2022
6.2.2 By Region - Global PD-L1 Biomarker Testing Platform Revenue, 2023-2028
6.2.3 By Region - Global PD-L1 Biomarker Testing Platform Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America PD-L1 Biomarker Testing Platform Revenue, 2017-2028
6.3.2 US PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.3.3 Canada PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.3.4 Mexico PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe PD-L1 Biomarker Testing Platform Revenue, 2017-2028
6.4.2 Germany PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.3 France PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.4 U.K. PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.5 Italy PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.6 Russia PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.7 Nordic Countries PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.4.8 Benelux PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia PD-L1 Biomarker Testing Platform Revenue, 2017-2028
6.5.2 China PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.5.3 Japan PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.5.4 South Korea PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.5.5 Southeast Asia PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.5.6 India PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America PD-L1 Biomarker Testing Platform Revenue, 2017-2028
6.6.2 Brazil PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.6.3 Argentina PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PD-L1 Biomarker Testing Platform Revenue, 2017-2028
6.7.2 Turkey PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.7.3 Israel PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.7.4 Saudi Arabia PD-L1 Biomarker Testing Platform Market Size, 2017-2028
6.7.5 UAE PD-L1 Biomarker Testing Platform Market Size, 2017-2028
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies PD-L1 Biomarker Testing Platform Major Product Offerings
7.1.4 Agilent Technologies PD-L1 Biomarker Testing Platform Revenue in Global Market (2017-2022)
7.1.5 Agilent Technologies Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche PD-L1 Biomarker Testing Platform Major Product Offerings
7.2.4 Roche PD-L1 Biomarker Testing Platform Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
PD L1 Biomarker Testing Platform Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|